...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: About that stroke failure

"Thanks.  Is it odd in your mind that it was ineffective for stroke?"

And I forgot to mention that there were no strokes reported in the post-hoc analysis of the Phase 2 ASSURE/SUSTAIN 5-point MACE. Therefore, there is no precedent in the Phase 2s that apabetalone lowered risk of stroke.

https://www.sciencedirect.com/science/article/pii/S0021915016300351

 

Share
New Message
Please login to post a reply